Contego Medical

Contego Medical

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://contegomedical.com

Last Round

Series E

Apr 19, 2023

Total Funding Raised

$67.5M

Momentum Score

25 /100

Company Overview

Contego Medical, Inc. is a private medical device company that develops and commercializes novel devices for cardiovascular and peripheral vascular procedures. The company's core technology is its Integrated Embolic Protection (IEP) platform, which combines the treatment device, such as a stent or balloon, with an embolic protection filter on a single catheter. This integrated design aims to simplify procedures, improve patient outcomes, and reduce the risk of stroke by capturing embolic debris that may be dislodged during an intervention. Founded in 2005, the company is based in Raleigh, North Carolina. As of January 2025, Medtronic serves as the exclusive U.S. distributor for Contego's products and holds an option to acquire the company.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

integrated embolic protectionIEPembolic protection devicecarotid artery stentingstroke preventioncarotid stentMedTechcardiovascular deviceperipheral vascular devicethrombectomy devicesingle catheter systemangioplasty ballooninterventional cardiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Contego Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Contego Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series EApr 19, 2023
Series DApr 12, 2022
Series CJun 8, 2020
Series BApr 17, 2015
Series A ExtensionMay 8, 2012

Key People

Founding team and executive leadership

Nathalie Greene

Chief Financial Officer

Executive Team

Contego Medical Investors

Notable investors and investment history

Contego Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Contego Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Contego Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersRaleigh, North Carolina
Employee Range49
Year Founded2005
Last FundingApr 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.